
98.62%
Purity
Passed full QC panel
- Variant
- Sermorelin 10mg
- Lot
- SERM0501
- Net Peptide Content
- 9.44 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics

Please confirm you are 21 years of age or older to enter.
By entering, you confirm that you are 21 years of age or older.
Valence Labs Research
Growth Hormone Research Peptide
Sermorelin is an analogue of growth hormone-releasing hormone corresponding to GHRH(1-29). It is studied in growth hormone-releasing hormone receptor research and pituitary signaling.
Research interest includes GH-axis biology and structure–activity relationships of the GHRH(1-29) sequence.
Sermorelin is studied as a GHRH(1-29) analogue in growth hormone-releasing hormone receptor research.
Research examines how this analogue relates to pituitary signaling within the GH axis.
Published structure–activity studies of hGHRH(1-29) have been used to examine how peptide sequence relates to GH-axis signaling.
Sermorelin and related GHRH(1-29) analogues have been examined in receptor, pituitary-signaling, and structure–activity research.
This page summarizes published research contexts. It does not present the Valence Labs catalog product as a therapeutic or provide treatment recommendations.
Catalog details for this product.

98.62%
Purity
Passed full QC panel
Sermorelin
10mg